Intellia Therapeutics

Intellia Therapeutics, Inc. is a clinical-stage biotechnology company that focuses on developing novel therapeutics using CRISPR-based technologies. The company aims to create potentially curative treatments for genetic diseases by leveraging its expertise in gene editing, setting it apart from competitors in the biotech industry. Intellia Therapeutics primarily targets patients with genetic disorders and the medical community seeking advanced gene-editing solutions.